DATAROMA
Home
Commentaries/Articles
Superinvestors
Activity
S&P500 Grid
Grand Portfolio
RealTime
Insider
22 Jul 2014
Bill Ackman: Will not raise offer for Allergan
( Portfolio )
Bill Ackman, Pershing Square, explains why he is not upping his bid for Allergan. The market clearly thinks the chance of Valeant buying Allergan has gone up, says Ackman.
Home
Help notes
Contact
Terms of Service
Privacy